Begins Coverage on OpGen (NASDAQ:OPGN) initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note published on Wednesday morning. The firm issued a sell rating on the medical research company’s stock. Separately, HC Wainwright cut shares of OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. Get […]

Leave a Reply

Your email address will not be published.

Previous post NeuroMetrix (NASDAQ:NURO) Now Covered by Analysts at
Next post Selecta Biosciences (NASDAQ:SELB) Now Covered by